Edaravone suspension for oral administration | Patent Number 11478450

US 11478450 B2
Application Number17560493
Publication NumberUS 20220110915 A1
Pendency10 months, 6 days
Filled DateDec 23, 2021
Priority DateNov 1, 2019
Publication DateApr 14, 2022
Expiration DateOct 31, 2039
Inventor/ApplicantsTetsuo Hayama
Tomohiro Takahashi
Tadashi Miyazawa
Tetsuo HAYAMA
Kouji Hayashi
Munetomo Matsuda
Munetomo MATSUDA
Tomoyuki OMURA
Tomoyuki Omura
Tadashi MIYAZAWA
Tomohiro TAKAHASHI
Kouji HAYASHI
ExaminesCHANNAVAJJALA, LAKSHMI SARADA
Art Unit1611
Technology Center1600
Assignments
Mitsubishi Chemical Group Corporation
Current
Mitsubishi Chemical Group Corporation
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.